Tri-level study: modification. Task 2: final report on driver/vehicle characteristics related to vehicle condition and causation and an assessment of Indiana PMVI effectiveness to reduce the frequency and severity of accident causes by vehicular-related malfunctions/degradations. Final report.

National Highway Traffic Safety Administration, Washington, D.C.

Tri-level accident research study, final report: January 1, 1975 - December 31, 1975.

National Highway Traffic Safety Administration, Washington, D.C.

Tri ėpokhi : Ekaterininskai͡a, Aleksandrovskai͡a, Nikolaevskai͡a : temy, biblīografīi͡a, voprosniki : posobīe dli͡a vyssheĭ shkoly i samoobrazovanīi͡a /

"Prilozhenīi͡a: 1) Russkīĭ teatr XVIII v. 2) Voronezhskoe kulʹturnoe gni͡ezdo. 3) Turgenev i 60-ye gody."

Hellēnides vivliographoi kai kyriai kōdikōn kata tous mesous aiōnas kai epi Tourkokratias, meta triōn panomoiotypōn /

Cover title.

Report of the tri-county study: Dickinson, Menomince, Delta.

Mode of access: Internet.

The tri-color; or, The Three days of blood, in Paris. With some other pieces.

Photocopy.

Tri simfonije.

Mode of access: Internet.

Lake Front Highway (F.A.P. 437) from Illinois Tri-State Tollway (I-94) to Grand Avenue (Illinois 132) in Lake County, Illinois : draft environmental impact statement.

Includes index.

Listi inu Evangelji, vʹ nedele, inu prasnike zeliga lejta, pod milostvim, visoko vrednim gospodam gospodam Augustinam, tri in dvajsetim shkofam lublanskim, pregledani, in med ludi dani, po dovoljenju vishih.

Bound as issued with Sveti postni Evangelji za vsah dan vʹ postu.

Tri politicheskii͡a︡ sistemy, Nikolai I [i.e. Pervyĭ], Aleksandr II [i.e. Vtoroĭ] i Aleksandr III [i.e. Tretiĭ] /

Photocopy.

[Caii Crispi Sallustii De coniuratione Catilinae historia. Caii Crispi Sallustii De bello Iugurthino historia. Caii Crispi Sallustii in M. Tul. Ciceronem oratio. M. T. Ciceronis in Crisp. Sallustium oratio. M. T. Ciceronis contra Catilinam oratio prima [-IIII]. Portii Latronis Declamatio contra Lucium Sergium Catilinam. Oratio Lepidi Cons. ad pop. rom. ex libris historiarum C. Crispi Salustii. Oratio L. Philippi in Senatu. Oratio C. Cottae Consulis ad populum. Oratio Macri Tri Pl. ad plebem. Epistola Cn. Pompeii ad Senatum. Rex Mirthridates regi Arsacis. Ad C. Caesarem de Republica ordinanda. Ad C. Caesarem Oratio de Republica ordinanda]

Contiene en las primeras páginas sin numerar: Ex libris Petri Criniti De historia, ac oratoribus Latinis, Sallustii uita. - Rursus alia Sallustii uita, incerto autore. - Iacobi Bononiensis in Catilinam Sallustii annotatiunculae. - Fragmentum Orationis Ciceronis pro M. Caelio.

Ueber tri-azoessigsaure und ihre derivate.

Thesis (doctoral)--

Beitrage zur kenntnis der tri- und der diphenylmethan-reihe.

Thesis (doctoral)--

Synthesis and immunological evaluation of M protein targeted tetra-valent and tri-valent group A streptococcal vaccine candidates based on the lipid-core peptide system

Group A streptococcus (GAS) is responsible for causing many clinical complications including the relatively benign streptococcal pharyngitis and impetigo. However. if left untreated. these conditions may lead to more severe diseases such as rheumatic fever (RF) and rheumatic heart disease (RHD). These diseases exhibit high morbidity and mortality, Particularly in developing countries and in indigenous populations of affluent countries. Only ever occur following GAS infection, a vaccine offers Promise for their Prevention. As stich, we have investigated the Use of the lipid-core peptide (LCP) system for the development of multi-valent Prophylactic GAS vaccines. The current study has investigated the capacity of this system to adjuvant LIP to four different GAS peptide epitopes. Presented are the synthesis and immunological assessment of tetra-valent and tri-valent GAS LCP systems. We demonstrated their capacity to elicit systemic IgG antibody responses in B10.BR mice to all GAS peptide epitopes. The data also showed that the LCP systems Were self-adjuvanting. These findings are particularly encouraging for the development of multi-valent LCP-based GAS vaccines.